ArticleCureus2026
Congo Red Unmasks the Culprit Behind Gastrointestinal Bleeding.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Immunoglobulin light chain (AL) amyloidosis arises from a plasma cell dyscrasia and is characterized by extracellular deposition of misfolded light chains. Gastrointestinal (GI) involvement is uncommon but clinically important because amyloid-related mucosal ischemia and vascular fragility can precipitate significant bleeding. A 65-year-old woman with systemic AL (lambda) amyloidosis with cardiac and renal involvement and stage II IgA lambda multiple myeloma presented with several hours of acute hematochezia. Her hemoglobin was 9.6 g/dL on presentation. Computed tomography angiography showed no active contrast extravasation, with mild-to-moderate distal rectal wall thickening and increased intraluminal fluid in the left colon. Colonoscopy on hospital day three demonstrated an adherent sigmoid clot (22-40 cm from the anal verge) without active bleeding; the examination was limited by clot burden. Four days later, she developed recurrent large-volume hematochezia with hemoglobin nadir of 7.9 g/dL. Repeat colonoscopy on hospital day seven demonstrated sigmoid ulceration at the prior clot site, and biopsies were obtained. Routine histopathology showed ulcerated granulation tissue consistent with ischemic-type mucosal injury. Congo red staining was focally positive for amyloid deposition, confirming colonic amyloid involvement. She was discharged without recurrent hematochezia. This case underscores the diagnostic value of requesting amyloid evaluation (including Congo red staining) when endoscopic findings and routine histology are non-specific, particularly in patients with known or suspected plasma cell dyscrasia and recurrent or unexplained GI bleeding.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.